CNRS

Company · FR · 1 documents

Key number

€50bn

Global investment in RNA technologies over the last 10 years. Jolt Capital p.10

Report

Jolt CapitalDecember 202416 pages

Over 10 billion doses of mRNA vaccines have been deployed globally with an estimated efficacy rate of 90%.